Transforming mental health care with psilocybin treatments.
APEX is a patient-driven pharmaceutical company.
Our mission is to develop and commercialize clinically evaluated psilocybin-derived treatments to tackle the most critical unmet need in depression, anxiety, and PTSD among Veterans and the general public.
Our vision is to work with regulators and advocacy groups to expedite our clinical programs and data capture to facilitate broader global access.
Addressing a sub-optimal standard of care
Despite being the current standard of care treatment for depression, anxiety and PTSD, studies estimate antidepressants improve symptoms in around half of patients, a coin toss at best.